Procedures	O
and	O
Outcomes	O

Patients	O
were	O
registered	O
,	O
after	O
giving	O
informed	O
consent	O
to	O
participate	O
,	O
in	O
a	O
web	O
-	O
based	O
eCRF	O
(	O
ORACLE	O
clinical	O
)	O
,	O
their	O
baseline	O
clinical	O
data	O
collected	O
and	O
then	O
randomly	O
assigned	O
1	O
:	O
1	O
to	O
the	O
investigational	O
treatment	O
,	O
stratified	O
by	O
study	O
site	O
.	O

CP	O
had	O
to	O
be	O
administered	O
immediately	O
after	O
randomization	O
(	O
day	O
1	O
)	O
.	O

Inpatients	O
were	O
assessed	O
daily	O
until	O
hospital	O
discharge	O
and	O
at	O
days	O
15	O
and	O
29	O
.	O

Assessments	O
in	O
discharged	O
patients	O
were	O
performed	O
either	O
as	O
outpatient	O
consultations	O
or	O
by	O
phone	O
.	O

The	O
patient	O
â€™	O
s	O
clinical	B-OutcomeDefinition
status	I-OutcomeDefinition
was	I-OutcomeDefinition
recorded	I-OutcomeDefinition
using	I-OutcomeDefinition
the	I-OutcomeDefinition
seven	I-OutcomeDefinition
-	I-OutcomeDefinition
category	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
COVID	I-OutcomeDefinition
-	I-OutcomeDefinition
19	I-OutcomeDefinition
scale	I-OutcomeDefinition
:	I-OutcomeDefinition
1	I-OutcomeDefinition
,	I-OutcomeDefinition
not	I-OutcomeDefinition
hospitalized	I-OutcomeDefinition
,	I-OutcomeDefinition
no	I-OutcomeDefinition
limitations	I-OutcomeDefinition
on	I-OutcomeDefinition
activities	I-OutcomeDefinition
;	I-OutcomeDefinition
2	I-OutcomeDefinition
,	I-OutcomeDefinition
not	I-OutcomeDefinition
hospitalized	I-OutcomeDefinition
,	I-OutcomeDefinition
limitation	I-OutcomeDefinition
on	I-OutcomeDefinition
activities	I-OutcomeDefinition
;	I-OutcomeDefinition
3	I-OutcomeDefinition
,	I-OutcomeDefinition
hospitalized	I-OutcomeDefinition
,	I-OutcomeDefinition
not	I-OutcomeDefinition
requiring	I-OutcomeDefinition
supplemental	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
;	I-OutcomeDefinition
4	I-OutcomeDefinition
,	I-OutcomeDefinition
hospitalized	I-OutcomeDefinition
,	I-OutcomeDefinition
requiring	I-OutcomeDefinition
supplemental	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
;	I-OutcomeDefinition
5	I-OutcomeDefinition
,	I-OutcomeDefinition
hospitalized	I-OutcomeDefinition
,	I-OutcomeDefinition
on	I-OutcomeDefinition
non	I-OutcomeDefinition
-	I-OutcomeDefinition
invasive	I-OutcomeDefinition
ventilation	I-OutcomeDefinition
or	I-OutcomeDefinition
high	I-OutcomeDefinition
flow	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
devices	I-OutcomeDefinition
;	I-OutcomeDefinition
6	I-OutcomeDefinition
,	I-OutcomeDefinition
hospitalized	I-OutcomeDefinition
,	I-OutcomeDefinition
on	I-OutcomeDefinition
invasive	I-OutcomeDefinition
mechanical	I-OutcomeDefinition
ventilation	I-OutcomeDefinition
or	I-OutcomeDefinition
ECMO	I-OutcomeDefinition
and	I-OutcomeDefinition
7	I-OutcomeDefinition
,	I-OutcomeDefinition
death	I-OutcomeDefinition
.	O

The	O
primary	O
outcome	O
was	O
the	O
proportion	B-PrimaryOutcome
of	I-PrimaryOutcome
patients	I-PrimaryOutcome
in	I-PrimaryOutcome
categories	I-PrimaryOutcome
5	I-PrimaryOutcome
,	I-PrimaryOutcome
6	I-PrimaryOutcome
or	I-PrimaryOutcome
7	I-PrimaryOutcome
at	B-TimeFrame
day	I-TimeFrame
15	I-TimeFrame
of	I-TimeFrame
the	I-TimeFrame
study	I-TimeFrame
.	O

Key	O
secondary	O
outcomes	O
were	O
time	B-SecondaryOutcome
to	I-SecondaryOutcome
improvement	I-SecondaryOutcome
of	I-SecondaryOutcome
one	I-SecondaryOutcome
category	I-SecondaryOutcome
on	I-SecondaryOutcome
the	I-SecondaryOutcome
ordinal	I-SecondaryOutcome
scale	I-SecondaryOutcome
;	O
mean	B-SecondaryOutcome
change	I-SecondaryOutcome
in	I-SecondaryOutcome
the	I-SecondaryOutcome
ordinal	I-SecondaryOutcome
scale	I-SecondaryOutcome
from	B-TimeFrame
baseline	I-TimeFrame
to	I-TimeFrame
days	I-TimeFrame
3	I-TimeFrame
,	I-TimeFrame
5	I-TimeFrame
,	I-TimeFrame
8	I-TimeFrame
,	I-TimeFrame
11	I-TimeFrame
,	I-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
29	I-TimeFrame
;	O
proportion	B-SecondaryOutcome
of	I-SecondaryOutcome
patients	I-SecondaryOutcome
in	I-SecondaryOutcome
categories	I-SecondaryOutcome
5	I-SecondaryOutcome
,	I-SecondaryOutcome
6	I-SecondaryOutcome
or	I-SecondaryOutcome
7	I-SecondaryOutcome
at	B-TimeFrame
day	I-TimeFrame
29	I-TimeFrame
;	O
mortality	B-SecondaryOutcome
at	B-TimeFrame
days	I-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
29	I-TimeFrame
;	O
duration	B-SecondaryOutcome
of	I-SecondaryOutcome
hospital	I-SecondaryOutcome
stay	I-SecondaryOutcome
;	O
number	B-SecondaryOutcome
of	I-SecondaryOutcome
days	I-SecondaryOutcome
alive	I-SecondaryOutcome
and	I-SecondaryOutcome
free	I-SecondaryOutcome
from	I-SecondaryOutcome
oxygen	I-SecondaryOutcome
support	I-SecondaryOutcome
;	O
number	B-SecondaryOutcome
of	I-SecondaryOutcome
days	I-SecondaryOutcome
alive	I-SecondaryOutcome
and	I-SecondaryOutcome
free	I-SecondaryOutcome
from	I-SecondaryOutcome
mechanical	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
.	I-SecondaryOutcome

Serial	B-OtherOutcome
naso	I-OtherOutcome
/	I-OtherOutcome
oropharyngeal	I-OtherOutcome
swabs	I-OtherOutcome
and	I-OtherOutcome
blood	I-OtherOutcome
samples	I-OtherOutcome
were	O
collected	O
at	B-TimeFrame
days	I-TimeFrame
3	I-TimeFrame
,	I-TimeFrame
5	I-TimeFrame
,	I-TimeFrame
8	I-TimeFrame
,	I-TimeFrame
11	I-TimeFrame
,	I-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
29	I-TimeFrame
,	O
and	O
tested	O
for	O
SARS	O
-	O
CoV	O
-	O
2	O
RNA	O
by	O
RT	O
-	O
PCR	O
assay	O
.	O

Serum	O
samples	O
were	O
tested	O
at	O
the	O
same	O
time	O
points	O
for	O
anti	O
SARS	O
-	O

CoV	O
-	O
2	O
IgG	O
.	O

Neutralizing	O
antibody	O
titers	O
were	O
determined	O
at	O
baseline	O
in	O
those	O
patients	O
with	O
positive	O
IgG	O
results	O
.	O

Serious	B-OtherOutcome
adverse	I-OtherOutcome
events	I-OtherOutcome
(	I-OtherOutcome
AE	I-OtherOutcome
)	I-OtherOutcome
,	O
grade	B-OtherOutcome
3	I-OtherOutcome
or	I-OtherOutcome
4	I-OtherOutcome
AE	I-OtherOutcome
and	O
infusion	B-OtherOutcome
related	I-OtherOutcome
AE	I-OtherOutcome
(	O
within	B-TimeFrame
24	I-TimeFrame
hours	I-TimeFrame
after	I-TimeFrame
administration	I-TimeFrame
)	O
were	O
collected	O
.	O

Investigators	O
were	O
instructed	O
to	O
actively	O
monitor	O
for	O
the	O
appearance	O
of	O
predefined	O
AE	O
of	O
Special	O
Interest	O
:	O
TRALI	O
and	O
ADE	O
(	O
antibody	O
-	O
dependent	O
enhancement	O
of	O
infection	O
)	O
.	O

